Poly Medicure Limited has intimated the BSE Limited and National Stock Exchange of India Limited about an upcoming meeting of its Board of Directors. The disclosure is made pursuant to Regulation 29(1)(a) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The Board meeting is scheduled to be held on Thursday, 05th November 2026. The primary agenda for the meeting is:
- To consider and approve the Unaudited Financial Results (both Consolidated and Standalone) of the company for the Second Quarter and Half Year ended on 30th September 2026.
- To transact any other matter which the Board may deem fit.
The company also confirmed the continuation of its closed trading window. The window for dealing in the company's securities was previously closed effective 28th September 2026 and shall now remain closed until 07th November 2026.
The intimation letter was signed by Mr. Avinash Chandra, Company Secretary (Membership No. A32270).